Navigation Links
Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
Date:11/18/2008

/p>

"This CE marking of the Tissue Genesis Cell Isolation System marks an important milestone for Bioheart as we transition into a commercial company," said Howard J. Leonhardt, Bioheart's Chairman, CEO and CTO. "We are extremely excited to commence shipping the systems to our customers."

In addition to the Bioheart license and distribution agreement, SpineSmith LP -- a developer of implants and biologics for surgical fixation, correction and tissue regeneration of the spine -- recently provided two Tissue Genesis Cell Isolation Systems, expected to be used in spinal fusion study.

"We expect the study of the use of Tissue Genesis Cell Isolation System fat derived stem cells to be a significant milestone for tissue regeneration. We look forward to helping surgeons harness the tremendous benefits of autologous adult stem cells from adipose for their spinal fusions," commented Kevin Dunworth, founder of SpineSmith.

Tissue Genesis also has a license and distribution agreement with Vet-Stem, Inc. "The CE mark is major milestone for the company. As the licensee for the world veterinary markets, the CE mark adds credibility and professionalism to a system that is already the leader in its class," Bob Harman, DVM, Vet-Stem CEO.

"Clearly, a demand for our technology exists," added Krucky. "We are committed to manufacturing and delivering systems of the highest quality to our current partners, as well as to potential licensees. The application of the CE mark on our Tissue Genesis Isolation System is a major step toward our commitment to European patients who will benefit from our technology -- We help you heal yourself(TM)."

About Tissue Genesis, Inc.

Tissue Genesis, Inc. (http://www.tissuegenesis.com) is a leader in adipose (fat) derived regenerative medicine solutions to address a wide range of therape
'/>"/>

SOURCE Tissue Genesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. New Edition of Definitive Resource in Tissue Engineering Released Today
2. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
3. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
4. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics Tissue of Origin Test Designed to Aid in Determination of a Tumors Origin
5. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
6. The closest look ever at native human tissue
7. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
8. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
9. Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp
10. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
11. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email: